The genetic basis of multiple sclerosis: a model for MS susceptibility

被引:9
|
作者
Goodin, Douglas S. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
来源
BMC NEUROLOGY | 2010年 / 10卷
关键词
NATIONWIDE COHORT; RECURRENCE RATES; TWIN CONCORDANCE; RISK; PREVALENCE; GENOMEWIDE; LOCI;
D O I
10.1186/1471-2377-10-101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: MS-pathogenesis is known to involve both multiple environmental events, and several independent genetic risk-factors. Methods: A model of susceptibility is developed and a mathematical analysis undertaken to elucidate the nature of genetic susceptibility to MS and to understand the constraints that are placed on the genetic basis of MS, both by the known epidemiological facts of this disease and by the known frequency of the HLA DRB1*1501 allele in the general populations of northern Europe and North America. Results: For the large majority of cases (possibly all), MS develops, in part, because an individual is genetically susceptible. Nevertheless, 2.2% or less of the general population is genetically susceptible. Moreover, from the model, the number of susceptibility-loci that need to be in a "susceptible allelic state" to produce MS-susceptibility is small (11-18), whereas the total number of such susceptibility-loci is large (50-200), and their "frequency of susceptibility" is low (i.e., <= 0.12). The optimal solution to the model equations (which occurs when 80% of the loci are recessive) predicts the epidemiological data quite closely. Conclusions: The model suggests that combinations of only a small number of genetic loci in a "susceptible allelic state" produce MS-susceptibility. Nevertheless, genome-wide associations studies with hundreds of thousands of SNPs, are plagued by both false-positive and false-negative identifications and, consequently, emphasis has been rightly placed on the replicability of findings. Nevertheless, because genome-wide screens don't distinguish between true susceptibility-loci and disease-modifying-loci, and because only true susceptibility-loci are constrained by the model, unraveling the two will not be possible using this approach. The model also suggests that HLA DRB1 may not be as uniquely important for MS-susceptibility as currently believed. Thus, this allele is only one among a hundred or more loci involved in MS susceptibility. Even though the "frequency of susceptibility" at the HLA DRB1 locus is four-fold that of other loci, the penetrance of those susceptible genotypes that include this allele is no different from those that don't. Also, almost 50% of genetically-susceptible individuals, lack this allele. Moreover, of those who have it, only a small fraction (<= 5.2%) are even susceptible to getting MS.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Adiponectin and not leptin is associated with genetic susceptibility to multiple sclerosis
    Kantorova, E.
    Cierny, D.
    Petrova, P.
    Slezak, P.
    Adam, T.
    Michalik, J.
    Sivak, S.
    Nosal, V.
    Kurca, E.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 459 - 459
  • [22] Serine and Kynurenine Metabolites in Genetic Susceptibility of Multiple Sclerosis
    Lin, X.
    Yang, Y.
    Simpson-Yap, S.
    Taylor, B.
    Zhou, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 16 - 17
  • [23] Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data
    O'Gorman, Cullen
    Lin, Rui
    Stankovich, James
    Broadley, Simon A.
    NEUROEPIDEMIOLOGY, 2013, 40 (01) : 1 - 12
  • [24] Serine and Kynurenine Metabolites in Genetic Susceptibility of Multiple Sclerosis
    Lin, X.
    Yang, Y.
    Simpson-Yap, S.
    Taylor, B.
    Zhou, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (4_SUPPL) : 16 - 17
  • [25] Genetic susceptibility to multiple sclerosis in Sardinians: an immunological study
    Sotgiu, S
    Serra, C
    Marrosu, MG
    Dolei, A
    Pugliatti, M
    Murgia, B
    Aiello, I
    Rosati, G
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (05): : 314 - 317
  • [26] Adiponectin and not leptin is associated with genetic susceptibility to multiple sclerosis
    Kantorova, E.
    Cierny, D.
    Petrova, P.
    Slezak, P.
    Michalik, J.
    Adam, T.
    Sivak, S.
    Nosal, V.
    Kurca, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 157 - 157
  • [27] Revealing the genetic basis of multiple sclerosis: are we there yet?
    Baranzini, Sergio E.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (03) : 317 - 324
  • [28] The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities
    Douglas S. Goodin
    BMC Neurology, 16
  • [29] Genetic susceptibility to multiple sclerosis: A candidate gene approach
    Liblau, R
    Reboul, J
    Mertens, C
    Eichenbaum, S
    Cournu, I
    Baberon, MC
    LyonCaen, O
    ClergeDarpoux, F
    Fontaine, B
    ANNALS OF NEUROLOGY, 1997, 42 (03) : M126 - M126
  • [30] Mapping genetic susceptibility and modeling pathogenesis in multiple sclerosis
    Baranzini, Sergio
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1814 - 1814